FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210367580> ?p ?o ?g. }

• W4210367580 endingPage "382" @default.
• W4210367580 startingPage "381" @default.
• W4210367580 abstract "INTRODUCTION AND OBJECTIVES Anatomic details affecting adverse outcomes following transcarotid artery stenting are not well characterized. We compared in-hospital outcomes following transcarotid artery revascularization (TCAR) and transfemoral carotid artery stenting (TFCAS) among symptomatic and asymptomatic patients stratified by degree of lesion calcification. METHODS Data from patients in the Society for Vascular Surgery Vascular Quality Initiative database undergoing TCAR (Jan 2017 to Apr 2020) or TFCAS (May 2005 to Apr 2020) and had carotid artery calcification grading was analyzed. Degree of calcification was stratified into three groups: none, <=50% calcification, and >50% calcification. RESULTS A total of 9,868 patients (TCAR:4,224; TFCAS:5,644) were included. TCAR patients were generally older, white, smokers, and had more comorbidities than TFCAS patients. Among symptomatic patients, there was no difference in rates of stroke, stroke/TIA, and MI by calcification severity between TCAR and TFCAS. However, there was a trend towards increased risk in all three events with higher calcification only after TFCAS. Symptomatic patients with severe (>50%) calcification had lower rates of death (TCAR:0.9% vs TFCAS:2.8%, P=0.013), stroke/death (TCAR:2.7% vs TFCAS:5.8%, P=0.006), stroke/death/MI (TCAR:3.3% vs TFCAS:6.5%, P=0.007), and postop complications (TCAR:6.0% vs TFCAS:12.4%, P<0.001) compared to TFCAS. Furthermore, TCAR had lower risk of death at all degrees of calcification compared to TFCAS. Similar findings were noted among asymptomatic TCAR patients with >50% calcification, in which the rates of death (TCAR:0.4% vs TFCAS:1.1%, P=0.080) and stroke/death (TCAR:1.5% vs TFCAS:3.1%, P=0.029) were reduced. CONCLUSIONS While increased calcification increased rates of adverse events after TFCAS, this trend was not observed after TCAR. Furthermore, TCAR had lower rates of death than TFCAS across all degrees of calcification and lower rates of stroke/death among patients with severe calcification. These findings suggesting that TCAR is protective against death despite anatomic differences and may be particularly beneficial over TFCAS in patients with calcified lesions. Anatomic details affecting adverse outcomes following transcarotid artery stenting are not well characterized. We compared in-hospital outcomes following transcarotid artery revascularization (TCAR) and transfemoral carotid artery stenting (TFCAS) among symptomatic and asymptomatic patients stratified by degree of lesion calcification. Data from patients in the Society for Vascular Surgery Vascular Quality Initiative database undergoing TCAR (Jan 2017 to Apr 2020) or TFCAS (May 2005 to Apr 2020) and had carotid artery calcification grading was analyzed. Degree of calcification was stratified into three groups: none, <=50% calcification, and >50% calcification. A total of 9,868 patients (TCAR:4,224; TFCAS:5,644) were included. TCAR patients were generally older, white, smokers, and had more comorbidities than TFCAS patients. Among symptomatic patients, there was no difference in rates of stroke, stroke/TIA, and MI by calcification severity between TCAR and TFCAS. However, there was a trend towards increased risk in all three events with higher calcification only after TFCAS. Symptomatic patients with severe (>50%) calcification had lower rates of death (TCAR:0.9% vs TFCAS:2.8%, P=0.013), stroke/death (TCAR:2.7% vs TFCAS:5.8%, P=0.006), stroke/death/MI (TCAR:3.3% vs TFCAS:6.5%, P=0.007), and postop complications (TCAR:6.0% vs TFCAS:12.4%, P<0.001) compared to TFCAS. Furthermore, TCAR had lower risk of death at all degrees of calcification compared to TFCAS. Similar findings were noted among asymptomatic TCAR patients with >50% calcification, in which the rates of death (TCAR:0.4% vs TFCAS:1.1%, P=0.080) and stroke/death (TCAR:1.5% vs TFCAS:3.1%, P=0.029) were reduced. While increased calcification increased rates of adverse events after TFCAS, this trend was not observed after TCAR. Furthermore, TCAR had lower rates of death than TFCAS across all degrees of calcification and lower rates of stroke/death among patients with severe calcification. These findings suggesting that TCAR is protective against death despite anatomic differences and may be particularly beneficial over TFCAS in patients with calcified lesions." @default.
• W4210367580 created "2022-02-08" @default.
• W4210367580 creator A5004647388 @default.
• W4210367580 creator A5029043155 @default.
• W4210367580 creator A5038695178 @default.
• W4210367580 creator A5043959948 @default.
• W4210367580 creator A5051966375 @default.
• W4210367580 creator A5069585081 @default.
• W4210367580 creator A5071744828 @default.
• W4210367580 creator A5071810251 @default.
• W4210367580 creator A5079204088 @default.
• W4210367580 creator A5086969335 @default.
• W4210367580 date "2022-02-01" @default.
• W4210367580 modified "2023-10-18" @default.
• W4210367580 title "Comparison of Transcarotid Artery Revascularization And Transfemoral Carotid Artery Stenting Outcomes Among Symptomatic And Asymptomatic Patients Based On Lesion Calcification" @default.
• W4210367580 doi "https://doi.org/10.1016/j.avsg.2021.12.021" @default.
• W4210367580 hasPublicationYear "2022" @default.
• W4210367580 type Work @default.
• W4210367580 citedByCount "0" @default.
• W4210367580 crossrefType "journal-article" @default.
• W4210367580 hasAuthorship W4210367580A5004647388 @default.
• W4210367580 hasAuthorship W4210367580A5029043155 @default.
• W4210367580 hasAuthorship W4210367580A5038695178 @default.
• W4210367580 hasAuthorship W4210367580A5043959948 @default.
• W4210367580 hasAuthorship W4210367580A5051966375 @default.
• W4210367580 hasAuthorship W4210367580A5069585081 @default.
• W4210367580 hasAuthorship W4210367580A5071744828 @default.
• W4210367580 hasAuthorship W4210367580A5071810251 @default.
• W4210367580 hasAuthorship W4210367580A5079204088 @default.
• W4210367580 hasAuthorship W4210367580A5086969335 @default.
• W4210367580 hasConcept C126322002 @default.
• W4210367580 hasConcept C127413603 @default.
• W4210367580 hasConcept C141071460 @default.
• W4210367580 hasConcept C164705383 @default.
• W4210367580 hasConcept C2777910003 @default.
• W4210367580 hasConcept C2780309369 @default.
• W4210367580 hasConcept C2780645631 @default.
• W4210367580 hasConcept C71924100 @default.
• W4210367580 hasConcept C78519656 @default.
• W4210367580 hasConceptScore W4210367580C126322002 @default.
• W4210367580 hasConceptScore W4210367580C127413603 @default.
• W4210367580 hasConceptScore W4210367580C141071460 @default.
• W4210367580 hasConceptScore W4210367580C164705383 @default.
• W4210367580 hasConceptScore W4210367580C2777910003 @default.
• W4210367580 hasConceptScore W4210367580C2780309369 @default.
• W4210367580 hasConceptScore W4210367580C2780645631 @default.
• W4210367580 hasConceptScore W4210367580C71924100 @default.
• W4210367580 hasConceptScore W4210367580C78519656 @default.
• W4210367580 hasLocation W42103675801 @default.
• W4210367580 hasOpenAccess W4210367580 @default.
• W4210367580 hasPrimaryLocation W42103675801 @default.
• W4210367580 hasRelatedWork W1975271362 @default.
• W4210367580 hasRelatedWork W1987215768 @default.
• W4210367580 hasRelatedWork W1995188757 @default.
• W4210367580 hasRelatedWork W2057721052 @default.
• W4210367580 hasRelatedWork W2314711404 @default.
• W4210367580 hasRelatedWork W2423950151 @default.
• W4210367580 hasRelatedWork W2763646354 @default.
• W4210367580 hasRelatedWork W3018830891 @default.
• W4210367580 hasRelatedWork W4229900919 @default.
• W4210367580 hasRelatedWork W4283155491 @default.
• W4210367580 hasVolume "79" @default.
• W4210367580 isParatext "false" @default.
• W4210367580 isRetracted "false" @default.
• W4210367580 workType "article" @default.